Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
Digital Innovation in Medication-Assisted Treatment for Opioid Use Disorder: A Stepped-Wedge Cluster Randomized Trial
This study has finished and is no longer accepting participants.
Multiple locations, including Anchorage
Strategies to Strengthen Physical and Mental Health During Hemodialysis: Rhythm of Life
This study has finished and is no longer accepting participants.
In IspartaCurrent recruitment status is unconfirmed.
Location not clearly listed
Researchers compared HS-10380 Low Dose, HS-10380 Medium dose, HS-10380 High Dose, Aripiprazole and placebo to find out how the approaches affected psychotic symptoms in adults with schizophrenia.
This study has finished and is no longer accepting participants.
In ShanghaiA Phase Ⅰ, Randomized, Double-blind, Placebo-controlled, Single Dose Ascending Study to Assess the Safety, Tolerability, and Pharmacokinetics of LPM787000048 Maleate Sustained-release Tablet (LY03020) in Chinese Healthy Adult Subjects
This study has finished and is no longer accepting participants.
In BeijingThis study evaluated the safety of SEP-363856 for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Glendale
A Retrospective Observational Study Based on the French National Health Insurance Database to Describe Antipsychotic Monotherapy and Polypharmacy Use, Including Loxapac, and to Investigate Their Association With Psychiatric Rehospitalization in Patients With Psychotic Disorders
This study has finished and is no longer accepting participants.
In HatfieldA Randomized Waitlist-controlled Trial to Evaluate of the Effectiveness of Immediate Treatment Compared to Deferred Treatment With the Fisher Wallace Stimulator FW-200 Device in First Responders With Self-reported Anxiety
This study has finished and is no longer accepting participants.
Multiple locations, including AtlantaCancer Anxiety Pilot Mindfulness Interdisciplinary Trial (CALM IT)
This study is no longer accepting new participants.
Multiple locations, including Basking RidgeResearchers compared Rapid Acting Intramuscular Olanzapine and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including FukushimaA Study Comparing the Effect of Atomoxetine Versus Other Standard Care Therapy on the Long Term Functioning in Attention-Deficit/Hyperactivity Disorder (ADHD) Children and Adolescents
Read the official source — NCT00447278A Randomized, Controlled, Open-Label Study of the Long-Term Impact on Functioning Using Atomoxetine Hydrochloride Compared to Other Early Standard Care in the Treatment of Attention-Deficit/Hyperactivity Disorder in Treatment-Naïve Children and Adolescents
This study has finished and is no longer accepting participants.
Multiple locations, including BrusselsThis study evaluated the safety and effectiveness of Aripiprazole for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including AnaheimWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.